A$0.13 BRN.AX BrainChip Holdings Ltd ASX pre market 17 Feb 2026: AI chip outlook

BRN.AX stock opened pre-market at A$0.13, down -10.34% on high volume. The share move follows recent weakness and there is an earnings date set for 04 Mar 2026. Volume is elevated at 11,603,895.00 shares versus an average of 9,372,947.00. We summarise valuation, technicals, Meyka AI forecasts and practical strategy for AI-focused investors in the ASX Technology sector.

BRN.AX stock: price action and liquidity

Shares trade at A$0.13 after a one-day drop of -10.34%. The stock opened at A$0.14, with a day low of A$0.13 and a day high of A$0.14. Volume today is 11,603,895.00, above the 50-day average volume of 9,372,947.00, showing higher-than-normal sell-side activity.

Trading has been weak year-to-date by -25.00% and one-year performance is -55.00%. The 50-day average price is A$0.17 and the 200-day average is A$0.20, indicating short- and medium-term downtrends.

Fundamentals and valuation for BrainChip Holdings Ltd (BRN.AX stock)

BrainChip reports EPS -0.02 and a trailing PE of -6.75, reflecting losses. Market capitalisation is A$318,391,868.00 with 2,358,458,279.00 shares outstanding. Book value per share is A$0.01 and cash per share is A$0.01, supporting a current ratio 5.18 that suggests short-term liquidity cover.

Price-to-sales is high at 171.21, and price-to-book is 13.03, which shows the market prices AI potential, not current revenue. R&D spend measures 5.23% of revenue, highlighting continued product development costs.

Technicals and Technology sector context for BRN.AX stock

Momentum indicators show an oversold bias: RSI 31.37 and CCI -121.79. ADX at 31.19 signals a strong directional trend. Bollinger bands sit at Upper A$0.18, Middle A$0.16, Lower A$0.13, so price is at the lower band.

The ASX Technology sector has been softer YTD at -9.61% and bears higher valuation multiples. That weak sector tone weighs on speculative AI names like BrainChip. Short-term technicals favour mean reversion, but trend risk remains.

Meyka AI grade and BRN.AX stock forecast

Meyka AI rates BRN.AX with a score out of 100. Meyka AI rates BRN.AX with a score of 64.73 / 100 and assigns a B grade with a HOLD suggestion. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

Meyka AI’s forecast model projects monthly A$0.11, quarterly A$0.09, and yearly A$0.17. Compared with the current price of A$0.13, the yearly forecast implies an implied upside of +27.88%. Forecasts are model-based projections and not guarantees.

Catalysts, risks and BRN.AX stock news

Key near-term catalyst is the earnings announcement on 04 Mar 2026. Positive revenue or partnership updates could narrow the valuation gap. Commercial adoption of the Akida neuromorphic processor remains the longer-term value driver.

Risks are clear: negative earnings, high price-to-sales, and a company rating of C- dated 13 Feb 2026 signalling weak fundamental metrics. For recent comparative industry commentary see Investing.com and company details at BrainChip.

Trading strategy and price targets for AI investors

For AI-focused portfolios, treat BRN.AX stock as speculative and size positions conservatively. Suggested scenario targets: conservative A$0.09, base A$0.17, and bull A$0.30. Use stop-losses near A$0.08 to limit downside.

Liquidity is acceptable with average volume 9,372,947.00 but volatility is high. Align any position with a time horizon for product adoption or clear revenue growth.

Final Thoughts

BrainChip Holdings Ltd (BRN.AX) is a small-cap AI chip play trading at A$0.13 in the ASX pre-market on 17 Feb 2026. Fundamentals show losses and rich valuation ratios, while technicals point to short-term oversold conditions. Meyka AI’s model projects a yearly A$0.17 target, implying a +27.88% upside from today’s price. That forecast reflects a balance of product potential and current financial weakness. Investors should weigh the upcoming 04 Mar 2026 earnings release, the company rating of C-, and execution risks. For AI sector exposure, consider limited allocation and clear exit rules. Meyka AI, our AI-powered market analysis platform, provides this data-driven view, but forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.